Hempalta (CVE:HEMP) Shares Up 33.3% – Should You Buy?

Hempalta Corp. (CVE:HEMPGet Free Report) shares rose 33.3% on Thursday . The company traded as high as C$0.07 and last traded at C$0.06. Approximately 182,500 shares traded hands during trading, an increase of 77% from the average daily volume of 103,117 shares. The stock had previously closed at C$0.05.

Hempalta Price Performance

The company has a current ratio of 3.99, a quick ratio of 0.88 and a debt-to-equity ratio of 28.72. The company’s 50 day moving average is C$0.05 and its 200-day moving average is C$0.09. The stock has a market cap of C$5.70 million, a PE ratio of -0.48 and a beta of -0.10.

Insider Buying and Selling at Hempalta

In other Hempalta news, Director Darren Hartley Bondar sold 453,000 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of C$0.06, for a total value of C$26,274.00. Insiders have bought 610,474 shares of company stock worth $27,499 over the last quarter. 27.90% of the stock is owned by corporate insiders.

About Hempalta

(Get Free Report)

Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products. The company also engages in the hemp carbon credit market.

Featured Articles

Receive News & Ratings for Hempalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempalta and related companies with MarketBeat.com's FREE daily email newsletter.